Elevated mRNA expression levels of MCM2, MCM4–7, and MCM10 were significantly related to short relapse-free survival (RFS), whereas MCM3 and MCM8 did not, indicating that they were related to poor prognosis in BC patients. This evidence concerns the gene MCM2 and breast cancer.